Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$595,806
in 1 filing, $596K under 10b5-1 plans

Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Heffernan Michael Thomas −$596K Director sold 86% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-17 Seiter Christopher Chief Financial Officer Grant or award · Stock Option (right to buy) +80,000 80,000
2020-02-13 Seiter Christopher Chief Financial Officer Grant or award · Stock Option (right to buy) +65,000 65,000
2019-06-03 Seiter Christopher Chief Financial Officer Grant or award · Stock Option (right to buy) +50,000 50,000

Page 1 of 1 · 3 trades